Jacobs & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.3M | Sell |
42,343
-778
| -2% | -$266K | 1.31% | 24 |
|
|
2026
Q1 | $15.2M | Sell |
43,121
-458
| -1% | -$163K | 1.5% | 19 |
|
|
2025
Q4 | $14.3M | Sell |
43,579
-1,480
| -3% | -$469K | 1.35% | 21 |
|
|
2025
Q3 | $12.7M | Buy |
45,059
+1,078
| +2% | +$313K | 1.22% | 31 |
|
|
2025
Q2 | $12.3M | Buy |
43,981
+62
| +0.1% | +$17.6K | 1.22% | 29 |
|
|
2025
Q1 | $13.7M | Sell |
43,919
-237
| -0.5% | -$70K | 1.46% | 20 |
|
|
2024
Q4 | $11.5M | Buy |
44,156
+78
| +0.2% | +$23.1K | 1.17% | 31 |
|
|
2024
Q3 | $14.2M | Sell |
44,078
-812
| -2% | -$266K | 1.42% | 20 |
|
|
2024
Q2 | $14M | Sell |
44,890
-363
| -0.8% | -$107K | 1.47% | 16 |
|
|
2024
Q1 | $12.9M | Sell |
45,253
-1
| -0% | -$293 | 1.36% | 27 |
|
|
2023
Q4 | $13M | Sell |
45,254
-739
| -2% | -$201K | 1.48% | 21 |
|
|
2023
Q3 | $12.4M | Sell |
45,993
-894
| -2% | -$223K | 1.54% | 17 |
|
|
2023
Q2 | $10.4M | Buy |
46,887
+726
| +2% | +$168K | 1.24% | 33 |
|
|
2023
Q1 | $11.2M | Buy |
46,161
+89
| +0.2% | +$21.8K | 1.38% | 25 |
|
|
2022
Q4 | $12.1M | Sell |
46,072
-719
| -2% | -$193K | 1.57% | 20 |
|
|
2022
Q3 | $10.5M | Sell |
46,791
-2
| -0% | -$485 | 1.52% | 18 |
|
|
2022
Q2 | $11.4M | Sell |
46,793
-873
| -2% | -$214K | 1.52% | 22 |
|
|
2022
Q1 | $11.5M | Buy |
47,666
+192
| +0.4% | +$44.1K | 1.28% | 30 |
|
|
2021
Q4 | $10.7M | Buy |
47,474
+1,452
| +3% | +$306K | 1.11% | 40 |
|
|
2021
Q3 | $9.79M | Buy |
46,022
+5,064
| +12% | +$1.17M | 1.13% | 38 |
|
|
2021
Q2 | $9.98M | Buy |
40,958
+2,054
| +5% | +$505K | 1.15% | 36 |
|
|
2021
Q1 | $9.68M | Buy |
38,904
+292
| +0.8% | +$69.7K | 1.18% | 37 |
|
|
2020
Q4 | $8.88M | Buy |
38,612
+203
| +0.5% | +$46.8K | 1.15% | 35 |
|
|
2020
Q3 | $9.76M | Sell |
38,409
-232
| -0.6% | -$57.5K | 1.42% | 24 |
|
|
2020
Q2 | $9.11M | Sell |
38,641
-1,438
| -4% | -$328K | 1.48% | 22 |
|
|
2020
Q1 | $8.13M | Buy |
40,079
+505
| +1% | +$110K | 1.57% | 20 |
|
|
2019
Q4 | $9.54M | Buy |
39,574
+655
| +2% | +$144K | 1.45% | 22 |
|
|
2019
Q3 | $7.53M | Sell |
38,919
-500
| -1% | -$96K | 1.22% | 32 |
|
|
2019
Q2 | $7.26M | Buy |
39,419
+234
| +0.6% | +$41.9K | 1.17% | 35 |
|
|
2019
Q1 | $7.44M | Hold |
39,185
| – | – | 1.27% | 32 |
|
|
2018
Q4 | $7.63M | Sell |
39,185
-669
| -2% | -$131K | 1.5% | 25 |
|
|
2018
Q3 | $8.26M | Sell |
39,854
-1,339
| -3% | -$264K | 1.4% | 27 |
|
|
2018
Q2 | $7.6M | Buy |
41,193
+1,441
| +4% | +$255K | 1.38% | 25 |
|
|
2018
Q1 | $6.78M | Buy |
39,752
+175
| +0.4% | +$32.1K | 1.25% | 34 |
|
|
2017
Q4 | $6.84M | Sell |
39,577
-662
| -2% | -$117K | 1.24% | 38 |
|
|
2017
Q3 | $7.5M | Sell |
40,239
-114
| -0.3% | -$20.2K | 1.41% | 31 |
|
|
2017
Q2 | $6.95M | Sell |
40,353
-7
| -0% | -$1.14K | 1.37% | 32 |
|
|
2017
Q1 | $6.62M | Sell |
40,360
-456
| -1% | -$75.8K | 1.36% | 32 |
|
|
2016
Q4 | $5.97M | Buy |
40,816
+2,230
| +6% | +$336K | 1.29% | 36 |
|
|
2016
Q3 | $6.44M | Buy |
38,586
+803
| +2% | +$136K | 1.44% | 29 |
|
|
2016
Q2 | $5.75M | Buy |
37,783
+2,270
| +6% | +$353K | 1.35% | 33 |
|
|
2016
Q1 | $5.32M | Buy |
35,513
+356
| +1% | +$52.9K | 1.28% | 32 |
|
|
2015
Q4 | $5.3M | Buy |
35,157
+1,607
| +5% | +$253K | 1.37% | 30 |
|
|
2015
Q3 | $4.64M | Buy |
33,550
+1,426
| +4% | +$225K | 1.23% | 33 |
|
|
2015
Q2 | $4.93M | Sell |
32,124
-234
| -0.7% | -$37.5K | 1.23% | 31 |
|
|
2015
Q1 | $5.17M | Buy |
32,358
+277
| +0.9% | +$43.6K | 1.31% | 29 |
|
|
2014
Q4 | $5.11M | Buy |
32,081
+2,116
| +7% | +$330K | 1.35% | 29 |
|
|
2014
Q3 | $4.21M | Buy |
29,965
+203
| +0.7% | +$26.5K | 1.19% | 32 |
|
|
2014
Q2 | $3.52M | Sell |
29,762
-26
| -0.1% | -$3.01K | 1.02% | 39 |
|
|
2014
Q1 | $3.67M | Hold |
29,788
| – | – | 1.14% | 31 |
|
|
2013
Q4 | $3.4M | Sell |
29,788
-164
| -0.5% | -$18.7K | 1.09% | 34 |
|
|
2013
Q3 | $3.35M | Sell |
29,952
-550
| -2% | -$59.6K | 1.17% | 33 |
|
|
2013
Q2 | $3.01M | Buy |
+30,502
| New | +$3.17M | 1.09% | 34 |
|
Other funds holding AMGN
Jacobs & Co's AMGN Position: Q2 2026 in Review
Jacobs & Co reduced its Amgen (AMGN) stake by 1.8% in Q2 2026, selling an estimated $266K and leaving 42,343 shares worth $15.3M. The position accounts for 1.31% of the portfolio, ranked #24.
Jacobs & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Jacobs & Co held 42,343 shares of Amgen worth $15.3M as of Q2 2026.
- Jacobs & Co sold 778 Amgen shares in Q2 2026, an estimated $266K.
- Amgen made up 1.31% of Jacobs & Co's portfolio in Q2 2026, its #24 holding.
- Jacobs & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.